Sarah Balderston ’18 was published in the peer-reviewed journal Nature Biomedical Engineering for her work as part of a larger research team that is exploring the diagnostic capabilities of CRISPR genetic technology. The paper, “,鈥� examines the validation of CRISPR SNP-chip technology for diagnosing sickle cell disease and ALS. Balderston, who is part of the Keck Graduate Institute research team, was listed as first author.